Clinical Trials

Registered clinical trials for treating the virus

Published and Preprint Papers

Drugs

Title

Altmetric

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.

An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.

hydroxychloroquine

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.

A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.

chloroquine, hydroxychloroquine

Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.

azithromycin, hydroxychloroquine

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.

chloroquine, hydroxychloroquine

Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial.